Search   
MSDS  : 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-
CAS  : 739-71-9
SYNONYMS  : * 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)- * 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine * 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl- * 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine * 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine * 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)a zepine * FI 6120 * IL 6001 * beta-Methylimipramine * 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile * 7162 RP * Sapilent * Surmontil * Surmontil 315695 * Trimeprimina * Trimeprimine * Trimeproprimine * Trimipramine
*** CHEMICAL IDENTIFICATION ***

RTECS NUMBER : HO1225000
CHEMICAL NAME : 5H-Dibenz(b,f)azepine,
5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-
CAS REGISTRY NUMBER : 739-71-9
BEILSTEIN REFERENCE NO. : 1321466
REFERENCE : 5-20-08-00099 (Beilstein Handbook Reference)
LAST UPDATED : 199612
DATA ITEMS CITED : 6
MOLECULAR FORMULA : C20-H26-N2
MOLECULAR WEIGHT : 294.48
WISWESSER LINE NOTATION : T C676 BN&T&J B1Y1&1N1&1
COMPOUND DESCRIPTOR : Drug
Mutagen
Human
SYNONYMS/TRADE NAMES :
* 5H-Dibenz(b,f)azepine,
10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-
* 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine
* 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-
* 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine
* 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine
* 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)a
zepine
* FI 6120
* IL 6001
* beta-Methylimipramine
* 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile
* 7162 RP
* Sapilent
* Surmontil
* Surmontil 315695
* Trimeprimina
* Trimeprimine
* Trimeproprimine
* Trimipramine

*** HEALTH HAZARD DATA ***

** ACUTE TOXICITY DATA **

TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Human
DOSE/DURATION : 18 mg/kg
TOXIC EFFECTS :
Cardiac - other changes
REFERENCE :
PSDTAP Proceedings of the European Society for the Study of Drug Toxicity.
(Princeton, NJ 08540) V.1-15, 1963-74. For publisher information, see
PESTD5. Volume(issue)/page/year: 6,171,1965

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 250 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica,
Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year:
102,753,1963

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 145 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - other changes
REFERENCE :
CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses
Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849-
Volume(issue)/page/year: 155,307,1961

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica,
Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year:
102,753,1963

TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 42 mg/kg
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity)
Behavioral - convulsions or effect on seizure threshold
Lungs, Thorax, or Respiration - other changes
REFERENCE :
CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses
Filiales. (SPPIF, B.P.22, F-41353 Vineuil, France) V.1- 1849-
Volume(issue)/page/year: 155,307,1961

*** STATUS IN U.S. ***

EPA GENETOX PROGRAM 1988, Inconclusive: Sperm morphology-human


*** END OF RECORD ***
Search More   
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
NAMECAS
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-morpholinopropionyl)- 18300-60-2
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-morpholinopropyl)- 18300-60-2
3,8-Diazabicyclo(3.2.1)octane,3-methyl-8-((2'-nitrothien-5'-yl)vinyl)carbonyl- 57269-49-5
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-10-chloro-3-(phenylmethyl)-,(+-)-, monomethanesulfonate 87255-61-6
5H-Dibenz(b,e)azepine,6,11-dihydro-5-(4-morpholinylacetyl)-,monohydrochloride 70337-07-4
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-phenethyl- 53873-58-8
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-(4-piperidino-4-carbamoylpiperidino)propyl)- 5942-95-0
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(2-piperidinoethyl)-,monohydrochloride 5942-95-0
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(m-(piperidinomethyl)benzoyl)-,hydrochloride 5942-95-0
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(o-(piperidinomethyl)benzoyl)-,hydrochloride 5942-95-0
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(p-(piperidinomethyl)benzoyl)-,hydrochloride 5942-95-0
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-(4-piperidinopiperidino)propyl)-,dihydrochloride 28028-19-5
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-piperidinopropionyl)- 26082-81-5
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(3-piperidinopropyl)- 26082-81-5
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-5,5-dimethyl-3-(phenylmethyl)-, (+-)-, (Z)-2-butenedioate (1:1) 87255-56-9
5H-Dibenz(b,e)azepine,6,11-dihydro-5-(1-piperidinylacetyl)-,monohydrochloride 70337-06-3
5H-Dibenz(b,f)azepine,10,11-dihydro-2-(1-piperidinylmethyl)- 64097-56-9
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-(2-propenyl)-,hydrochloride 65-15-6
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-propyl- 58335-95-8
5H-Dibenz(c,e)azepine, 6,7-dihydro-6-(2-propynyl)-,hydrochloride 51839-51-1
5H-Dibenz(b,e)azepine,6,11-dihydro-5-(1-pyrrolidinylacetyl)-,monohydrochloride 70337-09-6
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(2-(1-pyrrolidinyl)ethyl)-,monohydrochloride 70337-09-6
5H-Dibenz(b,f)azepine,10,11-dihydro-2-(1-pyrrolidinylmethyl)- 64097-59-2
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(m-(1-pyrrolidinylmethyl)benzoyl)-,hydrochloride 64097-59-2
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(o-(1-pyrrolidinylmethyl)benzoyl)-,hydrochloride 64097-59-2
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-6,6-dimethyl-3-(phenylmethyl)-, (+-)-, (Z)-2-butenedioate (1:1) 87255-69-4
5H-Dibenz(b,f)azepine,10,11-dihydro-5-(p-(1-pyrrolidinylmethyl)benzoyl)-,hydrochloride 87255-69-4
5H-Dibenz(b,f)azepine, 10-(2-(dimethylamino)ethyl)- 41972-85-4
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-5-ethyl- 84142-15-4
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-8-(ethylsulfonyl)-5-methyl-, hydrochloride 52813-92-0
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-8-(ethylthio)-5-methyl-,hydrochloride 52813-90-8
5H-Dibenz(b,f)azepine,10-(2-(dimethylamino)ethyl)-5-methyl- 30490-51-8
5H-Dibenz(b,f)azepine, 10-(2-(dimethylamino)ethyl)-,oxalate 101607-50-5
5H-Dibenz(b,f)azepine,5-(2'-(N,N-dimethylamino)-2'-methyl)ethyl- 63918-76-3
5H-Dibenz(b,f)azepine,10-(dimethylaminomethyl)-5-methyl-, hydrochloride 28941-77-7
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro- 739-71-9
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-6,6-dimethyl-, (+-)-,(Z)-2-butenedioate (1:1) 87255-66-1
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-,(-)- 3564-75-8
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-,(+)- 3564-66-7
5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)- 303-54-8
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro- 50-49-7
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, and3H-1,4- benzodiazepine,7-chloro-2-(methylamino)-5-phenyl-, 4-oxide (2:1) 63918-77-4
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, and2-((p-chlorobenzyl)(2-(dimethylamino)ethyl)amino)pyridine (1:1) 63918-77-4
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro- mixed withethyl alcoholSUBSTANCE DEFINITION :94% 5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-:6%ethyl alcoholREFERENCE :AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (HeymansInstitute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4-1898- Volume(issue)/page/year: 148,560,1964 63918-77-4
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-,monohydrochloride 113-52-0
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, 5-oxide 2207-85-4
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, 5-oxide,monohydrochloride 19864-71-2
3,7a-Diazacyclohepta(jk)fluoren-7(1H)-one,2,3,3a,4,5,6-hexahydro-5,5-dimethyl-, (+-)-,(Z)-2-butenedioate (1:1) 87255-59-2
5H-Dibenz(b,f)azepine,5-(3-(dimethylamino)propyl)-10,11-dihydro-, mixedwith sodium nitrite (1:4) 87255-59-2
5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-,fumarate 72629-48-2

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net